NASA's SpaceX Crew-9 completes research mission on ISS

Astronauts participating in NASA's SpaceX Crew-9 mission returned to Earth following an extended stay on the International Space Station (ISS). During their time aboard, the crew engaged in diverse research endeavors supporting the ISS National Laboratory, focusing on scientific advancements in health and agriculture.

Key projects included protein crystallization aimed at enhancing drug manufacturing and studies targeting neurodegenerative diseases such as Alzheimer's and Parkinson's. Participants included NASA astronauts Nick Hague, Suni Williams, and Butch Wilmore, alongside Roscosmos cosmonaut Aleksandr Gorbunov.

The Crew-9 mission encompassed various ISS National Lab-sponsored investigations, such as Bristol Myers Squibb's protein crystallization project and Sachi Bio’s evaluation of new therapeutics for treatment of neurodegenerative conditions. Notably, the University of California, Santa Barbara explored the impact of airway mucus on medication delivery, potentially improving drug administration for respiratory therapies.

Student-led projects also featured prominently, with contributions from Isabel Jiang via the Genes in Space program and the Student Spaceflight Experiments Program (SSEP), which involved multiple schools in experimental design focusing on diverse scientific questions.

The ISS National Lab continues to offer a platform for scientific research with implications for both earthly applications and future space activities. Those interested in the ongoing research initiatives can find more information on the missions and launches conducted with NASA's support.